Expert Interview
Looking at the FDA Approval of the Neffy Spray (intranasal ephinephrine) from ARS Pharmaceuticals for anaphylactic shock
Ticker(s): SPRY, PFE, AQSTInstitution: Children's Hospital Colorado
- Assistant Professor at the University of Colorado School of Medicine and Fellowship Director of Allergy and Immunology.
- Treats 12 patients with HAE, over 50 patients with spontaneous urticaria and 150 total patients with EoE.
- Clinical interests include food allergy, eosinophilic esophagitis, asthma, allergic rhinitis, eczema, drug allergy and urticaria.
How many patients do you manage for Anaphylactic Shock?
Added By: ben_adminWhat are your thoughts on the approval of the neffy spray?
Added By: ben_adminHow does the Neffy spray compare to the Epipen and other epinephrine medications?
Added By: ben_adminWill patients prefer a needle-free, nasally administered epinephrine medication?
Added By: ben_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
